View of A Prospective Cross-sectional study to evaluate the utility of Fibroscan and Serum Biomarkers (APRI, FIB-4) for Non-Invasive Diagnosis of Liver Fibrosis in Metabolic dysfunction associated fatty liver disease (MAFLD) patients in a tertiary care center

Return to Article Details A Prospective Cross-sectional study to evaluate the utility of Fibroscan and Serum Biomarkers (APRI, FIB-4) for Non-Invasive Diagnosis of Liver Fibrosis in Metabolic dysfunction associated fatty liver disease (MAFLD) patients in a tertiary care center Download Download PDF